Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy

Lung adenocarcinoma (LUAD) is a devastating disease with poor patient survival. Cancer immunotherapy has revolutionized the treatment of LUAD, but only a limited number of patients effectively respond to this treatment. Thus, the work to elucidate the LUAD immune heterogeneity could be crucial in de...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yang, Yan, Shi, Fan, Weina, Zhang, Mengyan, Liu, Wei, Lu, Hailing, Cao, Mengru, Hao, Chenguang, Chen, Lin, Tian, Fanglin, Zhan, Yuning, Cai, Li, Xing, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348081/
https://www.ncbi.nlm.nih.gov/pubmed/32719796
http://dx.doi.org/10.3389/fcell.2020.00550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348081/
https://www.ncbi.nlm.nih.gov/pubmed/32719796
http://dx.doi.org/10.3389/fcell.2020.00550

Ejemplares similares